BlossomHill Therapeutics, Inc. (BLSM) stock
BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.59−0.54 (-3.57%)
Close on Nov 18, 2026Market cap $37.18MP/E –Yield –
BlossomHill Therapeutics net income
Net income is the profit left for shareholders after every expense, interest and tax.
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$23.76M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.24M | – |
See a number that looks wrong?